Is Lymphatic Endoglin Expression a Risk Marker for Breast Cancer Metastasis? Results of a Pilot Study
Authors:
- 1 March 2013
- journal article
- Published by SAGE Publications in Lymphatic Research and Biology
- Vol. 11 (1) , 20-25
Abstract
Studies have identified endoglin as a biological marker that is overexpressed on the microvessels of certain solid cancers (breast, colorectal cancer, and head and neck squamous cell cancers). There is, at present, no immunohistochemical marker that can discriminate between lymph node-negative and or lymph node-positive breast cancer tissue. The expression of endoglin was quantified by immunohistochemistry and assessment of microvessel density in 53 surgical specimens. These were comprised of breast tumor tissue that had not spread to the regional lymph nodes (lymph node-negative breast tumor tissue: 20 specimens), breast tumor tissue had spread to regional lymph nodes (lymph node-positive breast tumor tissue: 21 specimens), and normal breast tissue as a control (12 specimens). Significant difference was observed between the expression of endoglin on microvessels of lymph node-negative and lymph node-positive breast cancer tissue (p0.05). These findings are the first to suggest that endoglin expression on breast tumor lymphatic vessels may have diagnostic potential as a discriminator between lymph node-negative and lymph node-positive breast cancer. Further studies would be required to confirm this.Keywords
This publication has 34 references indexed in Scilit:
- HIF‐1α: coordinates lymphangiogenesis during wound healing and in response to inflammationThe FASEB Journal, 2011
- Molecular Characterization of Dermal Lymphatic Endothelial Cells from Primary Lymphedema SkinLymphatic Research and Biology, 2011
- Blockade of Transforming Growth Factor-β1 Accelerates Lymphatic Regeneration during Wound RepairThe American Journal of Pathology, 2010
- Endothelial cells are activated during hypoxia via endoglin/ALK-1/SMAD1/5 signaling in vivo and in vitroBiochemical and Biophysical Research Communications, 2010
- Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysisJNCI: Journal of the National Cancer Institute, 2009
- Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesisBlood, 2008
- Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancerBreast Cancer Research and Treatment, 2006
- The Sialomucin CD34 Is a Marker of Lymphatic Endothelial Cells in Human TumorsThe American Journal of Pathology, 2006
- Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumoursEuropean Journal of Cancer, 2002
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987